<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-0319</journal-id>
<journal-title><![CDATA[Medicas UIS]]></journal-title>
<abbrev-journal-title><![CDATA[Medicas UIS]]></abbrev-journal-title>
<issn>0121-0319</issn>
<publisher>
<publisher-name><![CDATA[Universidad Industrial de Santander]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-03192020000100021</article-id>
<article-id pub-id-type="doi">10.18273/revmed.v33n1-2020003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características sociodemográficas y clínicas de pacientes con riesgo cardiovascular en una institución de atención ambulatoria durante 2015 y 2016]]></article-title>
<article-title xml:lang="en"><![CDATA[Sociodemographic and clinical characteristics of patients with cardiovascular risk in an institution of outpatient care during 2015 and 2016]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Osorio-Bedoya]]></surname>
<given-names><![CDATA[Edwin J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Restrepo-Garay]]></surname>
<given-names><![CDATA[Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Antioquia Medellín]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Medellín Antioquia]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Antioquia Medellín]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2020</year>
</pub-date>
<volume>33</volume>
<numero>1</numero>
<fpage>21</fpage>
<lpage>29</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-03192020000100021&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-03192020000100021&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-03192020000100021&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: el riesgo cardiovascular es la probabilidad de presentar enfermedad coronaria, enfermedad cerebrovascular o arteriopatía periférica en un periodo definido, usualmente 10 años. El conocimiento de las características de estos pacientes es fundamental para establecer la mejora de las condiciones de los pacientes.  Objetivo: determinar las características sociodemográficas y clínicas de los pacientes con riesgo cardiovascular de una institución de atención ambulatoria de Antioquia, Colombia, entre los años 2015 y 2016.  Materiales y métodos: estudio de corte transversal, sin restricción de edad, en participantes que utilizaban al menos un medicamento para hipertensión arterial, diabetes mellitus, dislipidemia o profilaxis cardiovascular, en el programa de riesgo cardiovascular de la ESE Hospital San Vicente de Paúl de Caldas de Antioquia.  Resultados: el estudio incluyó 157 pacientes, con una media de edad de 61,5 (DE 13,5). El 76,4% eran mujeres, el 43,9% convivían con pareja y el 76,4% presentaron un nivel educativo bajo. El 96,8% eran hipertensos, el 45,9% tenían dislipidemia, el 13,4% fumaban, el 10,8% consumían bebidas alcohólicas y el 58,6% realizaban actividad física de manera regular. El 44,6% presentaban riesgo cardiovascular alto, 43,3% bajo y 11,5% moderado. El 43,3% de los pacientes eran adherentes al tratamiento farmacológico y el 15,9% presentaban al menos una reacción adversa medicamentosa.  Conclusión: la alta proporción de pacientes con cifras de presión arterial en rangos normales predominó, pero presentando riesgo cardiovascular global moderado, lo que indica la necesidad de la continuidad de los programas de promoción y prevención en factores de Reemplazar por riesgo cardiovascular. MÉD. UIS.2020;33(1):21-9.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: cardiovascular risk is the probability of presenting coronary disease, cerebrovascular disease or peripheral arterial disease in a defined period, usually 10 years. The knowledge of the characteristics of these patients is essential to improvement the conditions of the patients. The knowledge of the characteristics of these patients is necessary to establish the most appropriate treatment.  Objective: to determine the sociodemographic and clinical characteristics of patients with cardiovascular risk at an outpatient care institution in Antioquia, Colombia, between 2015 and 2016.  Methods: cross-sectional study, without age restriction, who used at least one medication for hypertension, diabetes, dyslipidemia or cardiovascular prophylaxis in patients of the cardiovascular risk program at Hospital San Vicente de Paúl of Caldas Antioquia.  Results: the study included 157 patients, with a mean age of 61.5 (SD 13.5). 76.4% were female, 43.9% lived with partners and 76.4% had a low educational level. 96.8% were hypertensive, 45.9% had dyslipidemia, 13.4% smoked, 10.8% consumed alcoholic beverages and 58.6% were physically active. 44.6% presented high cardiovascular risk, 43.3% low and 11.5% moderate. 80.3% were controlled for their blood pressure, and the presence of dyslipidemia was present in 45.9%, 43.3% of patients were adherent to drug therapy and 15.9% had at least one adverse drug reaction. Conclusion: the high proportion of patients with blood pressure values in normal ranges predominated, but presenting moderate global cardiovascular risk, which indicates the need for continuity of promotion and prevention programs in CVR factors. MÉD.UIS.2020;33(1): 21-9.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Factores de riesgo]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Hipertensión]]></kwd>
<kwd lng="es"><![CDATA[Dislipidemia]]></kwd>
<kwd lng="en"><![CDATA[Risk factors]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular Diseases]]></kwd>
<kwd lng="en"><![CDATA[Hypertension]]></kwd>
<kwd lng="en"><![CDATA[Dyslipidemia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization.United Nations</collab>
<source><![CDATA[What is the deadliest disease in the world?]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>PAHO-WHO. Regional Mortality Information System.</collab>
<source><![CDATA[Cardiovascular diseases mortality by major groups of causes]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Ministerio de la Protección Social</collab>
<source><![CDATA[Encuesta Nacional de Salud - ENS 2007]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Ministerio de la Protección Social</collab>
<source><![CDATA[Análisis de Situación de Salud]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>República de Colombia. Ministerio de la Protección Social</collab>
<source><![CDATA[Decreto Número 2200 de 2005. Por el cual se reglamenta el Servicio Farmacéutico y se dictan otras disposiciones]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Ministerio de Salud y Protección Social - Colciencias</collab>
<source><![CDATA[Guía de práctica clínica hipertensión arterial primaria ( HTA )]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Ministerio de Salud y Protección Social - Colciencias</collab>
<source><![CDATA[Guía Práctica Clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Ministerio de Salud y Protección Social - Colciencias</collab>
<source><![CDATA[Guía Práctica Clínica para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias en la población mayor de 18 años]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Faus]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Martín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sabater-Hernández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[GarcíaJiménez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto del Método Dáder en el riesgo cardiovascular de pacientes ambulatorios (EMDADER-CV): métodos y resultados globales]]></article-title>
<source><![CDATA[Ars Pharmaceutica]]></source>
<year>2008</year>
<volume>49</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>7-24</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Chamorro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García-Jiménez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Chamorro]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Martínez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Merino]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of Pharmacotherapy Follow-Up for the Control of Hypertensive Patients in Community Pharmacies EMDADERHTA Study]]></article-title>
<source><![CDATA[Latin American Journal of Pharmacy]]></source>
<year>2013</year>
<volume>32</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>982-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular en pacientes con dislipidemia, afiliados al sistema de salud en Colombia]]></article-title>
<source><![CDATA[Rev Peru Med Exp Salud Pública]]></source>
<year>2013</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>205-11</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[CH.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de Riesgo para Enfermedad Cardiovascular en Trabajadores de una Institución Prestadora de Servicios de Salud, Colombia]]></article-title>
<source><![CDATA[Rev. Salud Pública]]></source>
<year>2007</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64-75</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lizarazu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Trespalacios]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular y evaluación del riesgo cardiovascular global en trabajadores de la Universidad Libre seccional Barranquilla]]></article-title>
<source><![CDATA[Salud Uninorte. Barranquilla (Col.)]]></source>
<year>2013</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>52-63</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendivil]]></surname>
<given-names><![CDATA[CO]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valoración del riesgo cardiovascular global y prevalencia de dislipemias según los criterios del NCEP-ATP III en una población adulta de Bogotá, Colombia]]></article-title>
<source><![CDATA[Clin Invest Arterioscl]]></source>
<year>2004</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>99-107</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[JA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular en indígenas de Riosucio-Caldas, 2010-2011]]></article-title>
<source><![CDATA[Revista Medicina U.P.B]]></source>
<year>2012</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-26</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosinach]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguimiento farmacoterapéutico desde una farmacia comunitaria en pacientes hipertensos no controlados]]></article-title>
<source><![CDATA[Farmacéuticos Comunitarios]]></source>
<year>2010</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sookaneknun]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Richards]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Sanguansermsri]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Teerasut]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacist involvement in primary care improves hypertensive patient clinical outcomes]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2004</year>
<volume>38</volume>
<page-range>20232038</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bofí]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influencia de los servicios de atención farmacéutica sobre los factores de riesgo cardiovascular, fidelización y satisfacción de los pacientes en la farmacia comunitaria (Proyecto FISFTES) Farmacéuticos]]></article-title>
<source><![CDATA[Comunitarios]]></source>
<year>2014</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>11-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Chamorro]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[García-Jiménez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Chamorro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Merino]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Martínez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of pharmacist involvement in adherence to medications in patients with high to moderate cardiovascular risk (Study EMDADER-CV-INCUMPLIMIENTO)]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2011</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>245-53</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manzur]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la Costa Caribe Colombiana (Estudio Caribe) Rev. Col]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2005</year>
<volume>12</volume>
<page-range>122-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palomo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Icaza]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mujica]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005]]></article-title>
<source><![CDATA[Rev Méd Chile]]></source>
<year>2007</year>
<volume>135</volume>
<page-range>904-12</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio EPRAS: studio poblacional del riesgo cardiovascular de una población colombiana]]></article-title>
<source><![CDATA[Rev Colomb Cardiol.]]></source>
<year>2014</year>
<volume>21</volume>
<page-range>284-93</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de los principales factores de riesgo de enfermedad cardiovascular y riesgo cardiovascular en pacientes con hipertensión arterial que asisten a una IPS en Bogotá y algunos municipios de Cundinamarca]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Pontificia Universidad Javeriana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abellán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of the degree of control of cardiovascular risk in patients with hypertension and diabetes in primary care]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2008</year>
<volume>40</volume>
<page-range>43-4</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Agredo]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El sedentarismo es un factor predictor de hipertrigliceridemia. Obesidad central y sobrepeso]]></article-title>
<source><![CDATA[Rev Colomb Cardiol]]></source>
<year>2012</year>
<volume>19</volume>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín-Baranera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Campo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coca]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[de la Figuera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ruilope]]></surname>
<given-names><![CDATA[LM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estratificación y grado de control del riesgo cardiovascular en la población hipertensa española. Resultados del estudio DICOPRESS]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2007</year>
<volume>129</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>247-51</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neto]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Marusic]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients]]></article-title>
<collab>de Lyra Junior DP.Pilger D.Cruciol-Souza JM.Gaeti WP</collab>
<source><![CDATA[J Pharm Pharm Sci]]></source>
<year>2011</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>249-63</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazroui]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[Kamal]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Ghabash]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Yacout]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Kole]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[McElnay]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus]]></article-title>
<source><![CDATA[BR J Clin Pharmacol]]></source>
<year>2009</year>
<volume>67</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>547-57</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
